Aug 03, 2016 - David Ricks will become Chairman of the Board and CEO of Eli Lilly in 2017 amidst a shifting but positive industry outlook.I took a look at a few more corporate governance trends including director te
Aug 03, 2016 - Sale of generic business to Teva closed, downside risk to stock removed.Sale of Anda Distribution business for $500M.Looking forward to share buybacks, further minor divestitures and revised guidance.
Aug 03, 2016 - The report from David Faber echoes one from the network's Meg Tiffell last night, but perhaps with more conviction. As for Merck ([[MRK]] -1.4%) - also rum
Aug 03, 2016 - Biogen's Q2 was very good.Shareholder returns are strong, balance sheet is looking very good.Takeover by either Allergan or Merck is a possibility.
Aug 03, 2016 - CELG has a complex story, not all of which is well-understood. In Part 2 of a mini-series beginning with Q2 results, this article reviews much of the pipeline and demonstrates that there is much promi
Aug 03, 2016 - Teva Pharmaceutical ([[TEVA]] +1%) CEO Erex Vigodman tells Bloomberg that the completion of its $40.5B purchase of Allergan's ([[AGN]] +1.6%) generics unit
Aug 03, 2016 - Biotech has continued its recent rally. A sell-off Tuesday was interrupted and reversed thanks to rumors about a possible buyout of Biogen.If this actually happens, it certainly would improve sentimen
Aug 03, 2016 - The reversal in oil prices to $40 a barrel is rippling through equity and bond markets, reigniting concerns about deeply indebted companies and countries reliant on commodities. Should oil slice thro
Aug 02, 2016 - Pfizer Investors Mood Dampened by Second Quarter Earnings, Stocks: PFE,HSP,AGN, release date:Aug 02, 2016
Aug 02, 2016 - Lumped in with Merck earlier on chatter that it would consider taking over Biogen (BIIB), Allergan (AGN) is unlikely to pursue such a deal, CNBC biotech/ph